Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Bellerophon Therapeutics (BLPH) Reports Q3 Loss of $0.37/Share
March 13, 2017 7:52 AM EDTBellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.37), versus ($0.83) reported last year.
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
... More